查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲家禽疫苗市场预测至 2031 年 - 区域分析 - 按类型、技术、剂型、疾病、给药途径和最终用户
市场调查报告书
商品编码
1597055

欧洲家禽疫苗市场预测至 2031 年 - 区域分析 - 按类型、技术、剂型、疾病、给药途径和最终用户

Europe Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User
出版日期: | 出版商: The Insight Partners | 英文 153 Pages | 订单完成后即时交付

价格

2023年欧洲家禽疫苗市值为3.2182亿美元，预计2031年将达到6.3501亿美元；预计2023年至2031年复合年增长率为8.9%。

不断成长的家禽业推动欧洲家禽疫苗市场

根据美国农业部 (USDA) 的报告，过去二十年来，家禽已成为全球消费最多的畜牧商品，特别是在发展中国家和新兴市场。此外，根据美国农业部的同一份报告，预计未来 10 年家禽仍将是全球进口量最大的畜牧商品。全球对家禽产品和进口的需求正在上升。随着可支配收入的增加，消费者转向购买蛋白质含量高的动物性家禽产品，特别是鸡肉。随着许多发展中经济体以及东南亚和撒哈拉以南非洲等新兴市场的快速城市化，家禽产品为消费者提供了负担得起的购买选择，因为家禽产品的蛋白质含​​量高，并且与其他肉类产品相比更容易获得那些很贵。为了满足家禽产品的需求和供应，一些国家正在关注国内家禽生产。这些国家包括美国、巴西、欧盟和泰国，它们也是主要的家禽出口国。根据外交关係委员会2024年报告，2021年美国、巴西、欧盟和泰国占全球家禽出口量的71%。产量将达到1,420 万吨。因此，不断增长的家禽业推动了家禽疫苗市场的成长。

欧洲家禽疫苗市场概况

在德国，家禽疾病的爆发正在显着增加。例如，德国在 2020 年 11 月至 2021 年 5 月期间经历了有史以来最大规模的高致病性禽流感疫情。圈养鸟类养殖场；以及1000多种野生鸟类。此外，在德国等国家，接种新城疫疫苗是一项重要的控制措施，因为该病毒在自由放养的鸟类中很常见。德国免疫常设兽医委员会 (StIKo Vet) 建议按照目前疫苗的产品特性摘要 (SPC)，每六週透过饮用水或喷雾使用减毒活疫苗对鸡隻进行重新接种。此外，艾美耳球虫疫苗接种是蛋鸡（无论是笼养还是放养的蛋鸡）的重要做法，以预防和控制艾美耳球虫病爆发的可能性。在饲养蛋鸡品种和混合遗传雏鸡的「雄性兄弟雏鸡」期间。因此，所有这些因素都促进了德国家禽疫苗市场的成长。

欧洲家禽疫苗市场收入及 2031 年预测（百万美元）

欧洲家禽疫苗市场区隔

欧洲家禽疫苗市场按类型、技术、剂型、疾病、给药途径、最终用户和国家分类。

根据类型，欧洲家禽疫苗市场分为肉鸡疫苗和蛋鸡疫苗。 2023 年，肉鸡细分市场将占据更大的市场份额。

从技术上来看，欧洲家禽疫苗市场分为减毒活疫苗、灭活疫苗和重组疫苗。减毒活疫苗细分市场在 2023 年占据最大的市场。

依剂型划分，欧洲家禽疫苗市场分为液体疫苗、冷冻干燥疫苗和粉状/粉状疫苗。 2023 年，液体疫苗领域占据最大的市场。

根据疾病，欧洲家禽疫苗市场分为禽流感、传染性支气管炎、马立克氏症、禽沙门氏菌病、传染性法氏囊病（IBD）、新城疫等。 2023 年，禽流感细分市场占最大市场。

从给药途径来看，欧洲家禽疫苗市场分为饮用水（D/W）、肌肉（I/M）、皮下（I/S）等。 2023 年，饮用水 (D/W) 领域占据最大的市场份额。

根据最终用户，欧洲家禽疫苗市场分为家禽养殖场和孵化场、兽医院以及家禽疫苗接种中心和诊所。 2023 年，家禽养殖场和孵化场领域占据最大的市场。

依国家划分，欧洲家禽疫苗市场分为德国、西班牙、法国、英国、义大利和欧洲其他地区。 2023年，德国在欧洲家禽疫苗市场份额中占据主导地位。

勃林格殷格翰国际有限公司、Zoetis Inc、BIOVAC、Phibro Animal Health Corp、Dechra Pharmaceuticals PLC、Elanco Animal Health Inc、Merck KGaA、Ceva 和 Vaccinova AB。是欧洲家禽疫苗市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

第 4 章：欧洲家禽疫苗市场 - 主要市场动态

  • 市场驱动因素
    • 家禽疾病盛行率上升
    • 不断发展的家禽业
  • 市场限制
    • 疫苗接种失败和处理不当
  • 市场机会
    • 政府对大规模疫苗接种活动和创新计画的支持
  • 未来趋势
    • 载体疫苗和联合疫苗的进展
  • 驱动因素和限制的影响：

第 5 章：欧洲家禽疫苗市场分析

  • 2021-2031年家禽疫苗市场收入

第 6 章：欧洲家禽疫苗市场分析 - 按类型

  • 概述
  • 肉鸡
  • 层

第 7 章：欧洲家禽疫苗市场分析 - 按技术

  • 概述
  • 减毒活疫苗
  • 灭活疫苗
  • 重组疫苗

第 8 章：欧洲家禽疫苗市场分析 - 按剂型

  • 概述
  • 液体疫苗
  • 冻干疫苗
  • 粉尘/粉状疫苗

第 9 章：欧洲家禽疫苗市场分析 - 按疾病

  • 概述
  • 禽流感
  • 禽沙门氏菌病
  • 马立克氏症
  • 传染性支气管炎 (IB)
  • 传染性法氏囊病 (IBD)
  • 新城疫
  • 其他的

第 10 章：欧洲家禽疫苗市场分析 - 按给药途径

  • 概述
  • 饮用水（干/干）
  • 肌肉注射 (I/M)
  • 皮下注射（S/C）
  • 其他的

第 11 章：欧洲家禽疫苗市场分析 - 按最终用户

  • 概述
  • 家禽养殖场
  • 兽医院
  • 家禽疫苗接种中心和诊所

第 12 章：欧洲家禽疫苗市场 - 国家分析

  • 欧洲市场概况
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 欧洲其他地区

第 13 章：产业格局

  • 概述
  • 家禽疫苗市场的成长策略
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 14 章：公司简介

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc
  • Merck KGaA
  • Ceva
  • Vaccinova AB

第 15 章：附录

Product Code: BMIRE00025385

The Europe poultry vaccines market was valued at US$ 321.82 million in 2023 and is expected to reach US$ 635.01 million by 2031; it is estimated to record a CAGR of 8.9% from 2023 to 2031.

Growing Poultry Industry Drives Europe Poultry Vaccines Market

According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world's largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world's poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.

Europe Poultry Vaccines Market Overview

In Germany, poultry disease outbreaks are rising significantly. For instance, Germany experienced the largest HPAI outbreak on record between November 2020 and May 2021. The outbreak affected 245 poultry; captive bird farms; and over 1,000 wild birds. Additionally, vaccination against Newcastle Disease is a crucial control measure in countries such as Germany, where the virus is common in the free-ranging bird population. The German Standing Veterinary Committee on Immunization (StIKo Vet) recommends revaccinating chickens every six weeks with attenuated live vaccines via drinking water or spray, following the Summary of Product Characteristics (SPCs) of current vaccines. Furthermore, Eimeria vaccination is an important practice in laying hens, both caged and free-range birds, to prevent and manage the possibility of suffering an outbreak of coccidiosis produced by Eimeria spp. during the rearing of "male brother chicks" of the layer breeds and mixed genetics chicks. Therefore, all these factors are contributing to the growth of the poultry vaccines market in Germany.

Europe Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Europe Poultry Vaccines Market Segmentation

The Europe poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Europe poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Europe poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Europe poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Europe poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Europe poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Europe poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Europe poultry vaccines market is segmented into Germany, Spain, France, the UK, Italy, and the Rest of Europe. Germany dominated the Europe poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Europe poultry vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

4. Europe Poultry Vaccines Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Poultry Diseases
    • 4.1.2 Growing Poultry Industry
  • 4.2 Market Restraints
    • 4.2.1 Vaccination Failure and Improper Handling
  • 4.3 Market Opportunities
    • 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
  • 4.4 Future Trends
    • 4.4.1 Advancements in Vectored and Combination Vaccines
  • 4.5 Impact of Drivers and Restraints:

5. Europe Poultry Vaccines Market Analysis

  • 5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Europe Poultry Vaccines Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Broiler
    • 6.2.1 Overview
    • 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Layer
    • 6.3.1 Overview
    • 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Poultry Vaccines Market Analysis - by Technology

  • 7.1 Overview
  • 7.2 Live Attenuated Vaccines
    • 7.2.1 Overview
    • 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Inactivated Vaccines
    • 7.3.1 Overview
    • 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Recombinant Vaccines
    • 7.4.1 Overview
    • 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Poultry Vaccines Market Analysis - by Dosage Form

  • 8.1 Overview
  • 8.2 Liquid Vaccines
    • 8.2.1 Overview
    • 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Freeze-Dried Vaccines
    • 8.3.1 Overview
    • 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Dust/Powdered Vaccines
    • 8.4.1 Overview
    • 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Poultry Vaccines Market Analysis - by Disease

  • 9.1 Overview
  • 9.2 Avian Influenza
    • 9.2.1 Overview
    • 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Avian Salmonellosis
    • 9.3.1 Overview
    • 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Marek's Disease
    • 9.4.1 Overview
    • 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Infectious Bronchitis (IB)
    • 9.5.1 Overview
    • 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Infectious Bursal Disease (IBD)
    • 9.6.1 Overview
    • 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Newcastle Disease
    • 9.7.1 Overview
    • 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Poultry Vaccines Market Analysis - by Route of Administration

  • 10.1 Overview
  • 10.2 Drinking Water (D/W)
    • 10.2.1 Overview
    • 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Intramuscular (I/M)
    • 10.3.1 Overview
    • 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Subcutaneous (S/C)
    • 10.4.1 Overview
    • 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Poultry Vaccines Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Poultry Farms
    • 11.2.1 Overview
    • 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Veterinary Hospitals
    • 11.3.1 Overview
    • 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Poultry Vaccination Centers & Clinics
    • 11.4.1 Overview
    • 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Poultry Vaccines Market - Country Analysis

  • 12.1 Europe Market Overview
    • 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 12.1.1.1 Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Overview
        • 12.1.1.1.2 Germany: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.1.6 Germany: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.1.7 Germany: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.2 Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Overview
        • 12.1.1.2.2 Spain: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.2.6 Spain: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.2.7 Spain: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.3 France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Overview
        • 12.1.1.3.2 France: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.3.3 France: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.3.5 France: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.3.6 France: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.3.7 France: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.4 United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Overview
        • 12.1.1.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.5 Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Overview
        • 12.1.1.5.2 Italy: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.5.6 Italy: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.5.7 Italy: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.6 Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Overview
        • 12.1.1.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Poultry Vaccines Market
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.1 Inorganic Developments
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Zoetis Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Phibro Animal Health Corp
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Dechra Pharmaceuticals PLC
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Elanco Animal Health Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Ceva
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Vaccinova AB
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Poultry Vaccines Market Segmentation
  • Table 2. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 3. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 5. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 6. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 7. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 8. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 10. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 11. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 12. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 13. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 16. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 17. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 18. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 19. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 20. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 21. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 22. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 23. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 24. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 25. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 26. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 27. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 28. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 29. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 30. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 31. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 32. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 33. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 34. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 35. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 36. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 37. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 38. Organic Developments Done by Companies
  • Table 39. Inorganic Developments Done by Companies
  • Table 40. Glossary of Terms, Poultry Vaccines Market

List Of Figures

  • Figure 1. Europe Poultry Vaccines Market Segmentation, by Country
  • Figure 2. Poultry Vaccines Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
  • Figure 5. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031
  • Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031
  • Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031
  • Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Marek's Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Poultry Vaccines Market Share (%) - by Route of Administration, 2023 and 2031
  • Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031
  • Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Europe: Poultry Vaccine Market - Revenue by Key Countries Revenue 2023 (US$ Million)
  • Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 35. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 36. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 37. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 38. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 39. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 40. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 41. Growth Strategies in the Poultry Vaccines Market